Skip to main content

Biocartis Idylla ctEGFR Mutation Assay

Biocartis has globally launched its Idylla ctEGFR Mutation Assay. The firm noted that the research-use-only tool is the liquid biopsy version of its solid biopsy Idylla EGFR Mutation Test. Running on the Idylla platform, the assay allows users to detect 49 EGFR mutations directly from 2 ml of blood plasma and provides resutls within 160 minutes, Biocartis said.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.